Coherus Biosciences Inc (CHRS) is up Friday morning, with the stock increasing 3.29% in pre-market trading to 2.2. CHRS's short-term technical score of 45 indicates that the stock has traded less bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, Coherus Biosciences Inc ranks higher than 63% of stocks. Coherus Biosciences Inc has fallen 36.42% over the past month, closing at $3.61 on November 3. During this period of time, the stock fell as low as $1.59 and as high as $3.73. CHRS has an average analyst recommendation of Strong Buy. The company has an average price target of $10.43.
CHRS has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on CHRS!